Cancer Research

Cancer represents a complex system of diseases characterized by the uncontrolled proliferation of anaplastic cells and their potential to metastasize. It is not merely a genetic disorder but a disruption of tissue architecture and microenvironmental homeostasis. The fundamental pathology is driven by the acquisition of biological capabilities—the hallmarks of cancer—including sustained proliferative signaling, evasion of growth suppressors, resistance to cell death, replicative immortality, induction of angiogenesis, and activation of invasion and metastasis. Understanding these hallmarks requires a holistic view of the tumor microenvironment (TME), where crosstalk between malignant cells, stromal fibroblasts, immune infiltrates, and the extracellular matrix dictates progression and therapeutic response.

Emerging Frontiers in Cancer Biology

Current research has shifted towards elucidating the plasticity of cancer cells and the metabolic reprogramming that fuels tumorigenesis. A significant hotspot involves the immune landscape of the TME, specifically how tumors establish an immunosuppressive niche to evade T-cell-mediated cytotoxicity. Furthermore, the role of epigenetic dysregulation—aberrant DNA methylation and histone modification—has emerged as a critical driver of transcriptional heterogeneity, allowing tumors to adapt to therapeutic stress. The study of circulating tumor DNA (ctDNA) and exosomes is also revolutionizing our ability to monitor tumor evolution non-invasively, offering a window into the dynamic changes occurring during metastasis and treatment resistance.

Elevating Discovery with Creative Biolabs

To navigate the complexities of cancer research, reliable detection tools are indispensable. Creative Biolabs offers a comprehensive portfolio of high-affinity antibodies validated for the study of fundamental cancer mechanisms. Our reagents are meticulously developed to detect key signaling proteins, cell cycle regulators, and apoptotic markers with exceptional specificity and sensitivity. Whether investigating signaling cascades or characterizing the tumor immune microenvironment, researchers can rely on our catalog to provide the consistent, reproducible data necessary to drive breakthrough discoveries in oncology. We invite you to explore our catalog and technical resources to accelerate your investigation into the mechanisms of cancer.

By Tumor Type Explore research tools and antibodies categorized by specific tumor types, allowing you to find validated reagents for your model system, from breast to lung cancer.

By Hallmark/Pathway Discover our portfolio based on the essential biological processes and signaling pathways, such as angiogenesis or cell cycle, that define the hallmarks of cancer.

Assay Routing Find the specific antibodies you need, conveniently organized by their validated application, including IHC, ELISA, Western Blot, flow cytometry, etc.

+ Filters

Mouse Anti-AKT1 (Phospho-Ser473) Recombinant Antibody (EC209) (V2LY-0624-LY209)

Compare

Target: AKT1 (Phospho-Ser473)

Host: Mouse

Antibody Isotype: IgG1, κ

Specificity: Human

Clone: EC209

Application*: WB, P